Turkey Lung Cancer Therapeutics Market Analysis

Turkey Lung Cancer Therapeutics Market Analysis

$ 3999

By 2030, it is anticipated that the Turkey Lung Cancer Therapeutics Market will reach a value of $462 Mn from $238 Mn in 2022, growing at a CAGR of 8.6% during 2022-30. The Lung Cancer Therapeutics Market in Turkey is dominated by a few domestic pharmaceutical companies such as Silanes, Liomont, and PISA. The Lung Cancer Therapeutics Market in Turkey is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Turkey lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.

ID: IN10TRPH041 CATEGORY: Pharmaceuticals GEOGRAPHY: Turkey AUTHOR: Dr. Vishwa Modhia

Buy Now

Turkey Lung Cancer Therapeutics Analysis Summary

By 2030, it is anticipated that the Turkey Lung Cancer Therapeutics market will reach a value of $462 Mn from $238 Mn in 2022, growing at a CAGR of 8.6% during 2022-30.

Turkey is an upper middle-income, developing transcontinental country located in Southeastern Europe and Southwestern Asia bordering the Black Sea. Lung cancer accounts for 17.6 % of all cancer forms in Turkey. With 41,000 new cases in 2020 and an age-adjusted incidence rate of 41.7 and 8.7 per 100,000 for men and women, Turkey ranks first. The most common subtype is non-small cell histology, which accounts for over 80% of all thoracic malignancies, half of which are adenocarcinomas, and small cell histology accounts for 16.5 %. Lung cancer detection and treatment in Turkey have advanced, as in many other nations throughout the world.

According to the most recent WHO data published in 2020, the number of lung cancer deaths in Turkey reached 35,070, accounting for 9.01 % of all deaths. Turkey ranks third in the world with an age-adjusted death rate of 39.65 per 100,000 inhabitants. Turkey's government spends 4.6% of its GDP on healthcare.

Turkey Lung Cancer Therapeutics Analysis

Market Dynamics

Market Growth Drivers

Currently, 14 Turkish cities have population-based cancer registry facilities, representing 50.2 % of the population. Turkey now has roughly 65,000 lung cancer patients, with a total estimated number of cancer cases related to smoking of approximately 31,000. Furthermore, Turkey benefits from an advantageous geopolitical location as well as a rapid economic rebound following COVID-19, making doing business easier. In 2022, Turkey would have 670 thoracic surgeons (0.79 per 100,000 people) conducting LC surgery in 126 institutions. Medicine prices in Turkey are incredibly low, routinely ranking lower than in several African countries. Radiation oncology is an essential component of the multidisciplinary treatment approach in Turkey. There will be 593 active radiation oncologists by December 2021. These aspects could boost Turkey's Lung Cancer Therapeutics market.

Market Restraints

Diagnostic and therapeutic facilities are not evenly accessible throughout the country, and making modern diagnostic and therapeutic facilities more accessible in rural areas is crucial. Given the high prevalence of lung carcinoma in Turkey, future goals include launching lung cancer screening programmes alongside smoking cessation programmes that are tailored to the country's requirements and resources. The manufacturing sector in Turkey is strongly reliant on imports. These factors may deter new entrants into the Turkey Lung Cancer Therapeutics market.

Competitive Landscape

Key Players

  • Laboratorios Silanes: Silanes is a Mexican pharmaceutical company that specializes in the development and production of innovative medicines for various health conditions, including cancer. They have a range of oncology products, including those for lung cancer
  • Laboratorios Liomont: Liomont is a Mexican pharmaceutical company that produces and markets a range of medicines for various therapeutic areas, including oncology
  • Laboratorios PISA: PISA is a Mexican pharmaceutical company that focuses on the development and production of generic medicines. They offer a range of oncology products, including those for lung cancer
  • Grupo Biotoscana: Biotoscana is a biopharmaceutical company that focuses on the development, production, and distribution of speciality and orphan drugs in Latin America
  • Rimsa: Rimsa is a Mexican pharmaceutical company that produces and distributes a range of prescription and over-the-counter medicines. They have a range of oncology products, including those for lung cancer

Healthcare Policies and Reimbursement Scenarios

The Turkish Medicines and Medical Devices Agency (TITCK) is the regulatory authority in Turkey in charge of authorising and regulating therapeutic medications. The Turkish Government's Social Security Institution (SSI) reimburses 86 % of the population in the Turkish healthcare system. Turkey boasts one of the world's most admired social security systems, providing its residents with free healthcare and access to a lengthy variety of cutting-edge cancer medications. However, with one of Europe's youngest populations, the system's sustainability is dubious as its exceptionally youthful population ages and cancer incidence rises.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Lung Cancer Therapeutics Segmentation

By Type (Revenue, USD Billion):

  • Small Cell Lung Cancer
  • Non-small Cell Lung Cancer
  • Lung Carcinoid Tumor

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
  • Others

By Type of Molecule (Revenue, USD Billion):

  • Small Molecules
  • Biologics

By Drug Class (Revenue, USD Billion):

  • Alkylating Agents
  • Antimetabolites
  • Multikinase Inhibitors
  • Mitotic Inhibitors
  • EGFR Inhibitors
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 12 February 2024
Updated by: Dhruv Joshi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter